Table 3.
Operative method, outcome, tumor size, histological type, pathological stage, and adjuvant chemotherapy
| FNA+ | FNA- | ||
| Number of patients | 54 | 28 | |
| Operative method (%) | |||
| PD | 59.3 (32/54) | 75 (21/28) | NS1 |
| DP | 38.9 (21/54) | 17.9 (5/28) | |
| TP | 1.9 (1/54) | 3.6 (1/28) | |
| Partial resection | 1.9 (1/54) | 3.6 (1/28) | |
| Outcome (%) | |||
| R0 | 96.3 (52/54) | 96.4 (27/28) | NS1 |
| R1 | 3.7 (2/54) | 3.6 (1/28) | |
| R2 | 0 (0/54) | 0 (0/28) | |
| Tumor size (mm) | 30.0 ± 1.9 SD | 29.5 ± 2.5 SD | NS1 |
| Histological type | |||
| Adenocarcinoma | 53 | 26 | NS1 |
| Adenosquamous carcinoma | 1 | 0 | |
| IPMC | 0 | 2 | |
| UICC (%) | |||
| 0 | 0 (0/54) | 3.6 (1/28) | NS1 |
| IA | 3.7 (2/54) | 7.1 (2/28) | |
| IB | 1.9 (1/54) | 0 (0/28) | |
| IIA | 48.1 (26/54) | 21.4 (6/28) | |
| IIB | 38.9 (21/54) | 53.6 (15/28) | |
| III | 3.7 (2/54) | 3.6 (1/28) | |
| IV | 3.7 (2/54) | 10.7 (3/28) | |
| AC administration (%) | 74.1 (40/54) | 50 (14/28) | P < 0.051 |
1
Pearson’s χ2 test. FNA+: The patient group who underwent endoscopic ultrasound-guided fine-needle aspiration before surgery; FNA-: The patient group who did not undergo endoscopic ultrasound-guided fine-needle aspiration before surgery; PD: Pancreatoduodenectomy; DP: Distal pancreatectomy; TP: Total pancreatectomy; SD: Standard deviation; IPMC: Intraductal papillary mucinous carcinoma of the pancreas; UICC: Pathological stage of the Union Internationale Contre le Cancer; AC: Adjuvant chemotherapy.